Concepedia

Author

P. Contreras

Monsanto (United States)

Also Known As

P C Contreras, P CONTRERAS, P Contreras, P. C. Contreras, P. Contreras, P.C Contreras, P.C. Contreras, Pamela Contreras, Patricia C. Contreras

31

Publications

1.1K

Citations

16

H-Index

46

Concepts

All Affiliations

Monsanto (United States)West Chester UniversitySea Turtle Conservancy
PC

About

P. Contreras is an author at Monsanto (United States) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

789

2

Social Sciences

4

4

336

3

Health Sciences

2

2

164

4

Natural Sciences

2

2

68

5

Biochemistry

2

2

68

P. Contreras

×

17

Publications

1.1K

Citations

16

H-Index

YearCitations

Insulin-like Growth Factor-1 (IGF-1) Improves both Neurological Motor and Cognitive Outcome Following Experimental Brain Injury

Kathryn E. Saatman, P. Contreras, Douglas H. Smith,

Experimental Neurology

1997

186

Acute gastrointestinal effects of graded levels of copper in drinking water.

Fernando Pizarro, Manuel Olivares, Ricardo Uauy,

Environmental Health Perspectives

1999

138

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine

Thomas M. Engber, Shelley A Dennis, B. E. Jones,

Neuroscience

1998

99

Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.

P. Contreras, A.E. Takemori

Journal of Pharmacology and Experimental Therapeutics

1984

82

Clozapine attenuates N-methyl-d-aspartate receptor complex-mediated responses in vivo: tentative evidence for a functional modulation by a noradrenergic mechanism

Tadimeti S. Rao, P. Contreras, Julie A. Cler,

Neuropharmacology

1991

73

Evidence for a role of glutamate decarboxylase activity as a regulatory mechanism of cerebral excitability

Ricardo Tapia, María‐Elena Sandoval, P. Contreras

Journal of Neurochemistry

1975

65

Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice.

P. Contreras, C. W. Steffler, E. Dyakova Yu.,

Journal of Pharmacology and Experimental Therapeutics

1995

57

PCP‐induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP‐receptor‐acylating agent

Carol A. Tamminga, Kenji Tanimoto, S. Kuo,

Synapse

1987

50

Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil

P. Contreras, Diane M. Ragan, Margaret E. Bremer,

Brain Research

1991

49

Opipramol, a potent sigma ligand, is an anti-ischemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements

Tadimeti S. Rao, Julie A. Cler, STEPHEN J. MICK,

Neuropharmacology

1990

44

Page 1